This virtual FASEB Science Research Conference (SRC) has been held every two years since 1995 and remains one of the best-attended and highly regarded focused meetings in the basic biology and therapeutic targeting of these tumors. The virtual conference brings together biochemists, geneticists, molecular biologists, and clinicians interested in the pathophysiology of leukemias and lymphomas, and the development of novel therapies for these diseases.
*Registration for this conference will open early 2021.
Kathrin Bernt, MD
Assistant Professor of Pediatrics, Children's Hospital of Philadelphia, PA, USA
Michael Kharas, PhD
Associate Member, Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Email Sign Up
Sign up for emails to receive updates and information this conference.